These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 9715818)

  • 1. The sympathetic nervous system in chronic heart failure.
    Joseph J; Gilbert EM
    Prog Cardiovasc Dis; 1998; 41(1 Suppl 1):9-16. PubMed ID: 9715818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sympathetic activation and the role of beta-blockers in chronic heart failure.
    Krum H
    Aust N Z J Med; 1999 Jun; 29(3):418-27. PubMed ID: 10868514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The sympathetic nervous system in heart failure physiology, pathophysiology, and clinical implications.
    Triposkiadis F; Karayannis G; Giamouzis G; Skoularigis J; Louridas G; Butler J
    J Am Coll Cardiol; 2009 Nov; 54(19):1747-62. PubMed ID: 19874988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beta-adrenergic blockade in chronic heart failure: principles, progress, and practice.
    Packer M
    Prog Cardiovasc Dis; 1998; 41(1 Suppl 1):39-52. PubMed ID: 9715822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rationale for beta-adrenergic blocking drugs in cardiomyopathy.
    Fowler MB; Bristow MR
    Am J Cardiol; 1985 Apr; 55(10):120D-124D. PubMed ID: 2859789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rationale for treatment of patients with chronic heart failure with adrenergic blockade.
    Sackner-Bernstein JD; Mancini DM
    JAMA; 1995 Nov; 274(18):1462-7. PubMed ID: 7474194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting Adrenergic Receptors in Metabolic Therapies for Heart Failure.
    Perez DM
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34071350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cellular and physiologic effects of beta blockers in heart failure.
    Sabbah HN
    Clin Cardiol; 1999 Oct; 22 Suppl 5():V16-20. PubMed ID: 10526699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sympathetic activation in heart failure and its treatment with beta-blockade.
    Pepper GS; Lee RW
    Arch Intern Med; 1999 Feb; 159(3):225-34. PubMed ID: 9989534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is activation of the sympathetic nervous system beneficial or detrimental to the patient with chronic heart failure? Lessons learned from clinical trials with beta-adrenergic agonists and antagonists.
    Packer M
    J Cardiovasc Pharmacol; 1989; 14 Suppl 5():S38-43. PubMed ID: 2478808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Catecholamines and their blockade in congestive heart failure.
    White CM
    Am J Health Syst Pharm; 1998 Apr; 55(7):676-82. PubMed ID: 9558423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adrenergic signaling in heart failure: a balance of toxic and protective effects.
    Baker AJ
    Pflugers Arch; 2014 Jun; 466(6):1139-50. PubMed ID: 24623099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonselective versus selective beta-adrenergic receptor blockade in congestive heart failure: differential effects on sympathetic activity.
    Azevedo ER; Kubo T; Mak S; Al-Hesayen A; Schofield A; Allan R; Kelly S; Newton GE; Floras JS; Parker JD
    Circulation; 2001 Oct; 104(18):2194-9. PubMed ID: 11684630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The paradox of beta-adrenergic blockade for the management of congestive heart failure.
    Eichhorn EJ
    Am J Med; 1992 May; 92(5):527-38. PubMed ID: 1349791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biologic rationale for the use of beta-blockers in the treatment of heart failure.
    Sabbah HN
    Heart Fail Rev; 2004 Apr; 9(2):91-7. PubMed ID: 15516856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The neuroendocrine and sympathetic nervous system in congestive heart failure.
    Ferrari R; Ceconi C; Curello S; Visioli O
    Eur Heart J; 1998 Jun; 19 Suppl F():F45-51. PubMed ID: 9651735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The potential beneficial effects of beta adrenergic blockade in the treatment of ventricular fibrillation.
    Bassiakou E; Xanthos T; Papadimitriou L
    Eur J Pharmacol; 2009 Aug; 616(1-3):1-6. PubMed ID: 19555681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of functional capacity and survival in congestive heart failure. Effects of activation of the sympathetic nervous system.
    Packer M
    Postgrad Med; 1988 Feb; Spec No():96-103. PubMed ID: 2894667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute effects of beta 1-selective and nonselective beta-adrenergic receptor blockade on cardiac sympathetic activity in congestive heart failure.
    Newton GE; Parker JD
    Circulation; 1996 Aug; 94(3):353-8. PubMed ID: 8759076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Therapy of heart failure with beta-blockers?].
    Osterziel KJ; Dietz R
    Z Kardiol; 1997 Jan; 86(1):1-8. PubMed ID: 9133118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.